Ann: Immutep to present TACTI-002 phase 2 data at SITC 2020, page-28

Actually there might be a little bit new in the presentation last night.
The bit above was not included in the ESMO poster for the HNSCC and because of the embargo for the coming meeting for next week, our Prof. can only slightly indicate something.
That tell me the new data cut off for the next week poster is going to look even better, might be with target lesion further shrink or effect penetrate deeper as what exactly says here. Surely longer survival as we have 3 months more passing now and plus the new stage 2 paitient data.........

Let's wait and see..........